[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Insulinoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

February 2019 | 40 pages | ID: 21D0DA749D6EN
VPAResearch

US$ 2,199.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The ongoing clinical trial research report- “2019 Insulinoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Insulinoma trials across the world. The report presents top level analysis of global Insulinoma clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Insulinoma trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Insulinoma clinical trials by-
  • Region (Asia Pacific, Europe, Middle East Africa and Americas)
  • Countries
  • Trial Phase
  • Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
  • Type of the trial (Interventional, Observational)
  • Sponsor Type (Companies, Universities, Government Bodies etc)
  • Enrollment across types, sponsor types, geographies, current status and phases
The report also identifies the potential drug candidates under development for treatment of Insulinoma on the basis of intervention type ongoing Insulinoma trials.

The research work is prepared through extensive and continuous research on Insulinoma trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

REPORT SCOPE AND COVERAGE:
  • All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Insulinoma patients are identified
  • The report includes panorama of ongoing Insulinoma clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Insulinoma clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Insulinoma Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
  2.2.1 Ongoing Insulinoma Clinical Trials by Region
  2.2.2 Average Enrollment of Insulinoma Clinical Trials
  2.2.3 Companies participating in Ongoing Trials
  2.2.4 Drugs under Study for Insulinoma Treatment, 2019

3. REGION WISE INSULINOMA CLINICAL TRIALS

3.1 Asia Pacific Insulinoma Clinical Trials by Country
3.2 Europe Insulinoma Clinical Trials by Country
3.3 North America Insulinoma Clinical Trials by Country
3.4 Middle East and Africa Insulinoma Clinical Trials by Country
3.5 South and Central America Insulinoma Clinical Trials by Country

4. INSULINOMA CLINICAL TRIAL TRENDS

4.1 Start Year wise Ongoing Insulinoma Clinical Trials
4.2 Phase wise Ongoing Insulinoma Clinical Trials
4.3 Trial Status wise Ongoing Insulinoma Clinical Trials
4.4 Trial Type wise Ongoing Insulinoma Clinical Trials

5. INSULINOMA AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Insulinoma Trials by Year
5.2 Average Enrollment in Insulinoma Trials by Phase
5.3 Average Enrollment in Insulinoma Trials by Status
5.4 Average Enrollment in Insulinoma Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONGOING INSULINOMA CLINICAL TRIALS

6.1 Ongoing Insulinoma Trials by Sponsor Type
6.2 Insulinoma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ongoing Insulinoma Trials- Phase
7.2 Ongoing Insulinoma Trials- Phase
7.3 Ongoing Insulinoma Trials- Phase
7.4 Ongoing Insulinoma Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Insulinoma Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Figure 9: Insulinoma Ongoing Clinical Trials by Phase
Figure 10: Insulinoma Ongoing Clinical Trials by Trial Status
Figure 11: Insulinoma Ongoing Clinical Trials by Type
Figure 12: Insulinoma Ongoing Clinical Trials by Sponsor Type
Figure 13: Insulinoma Ongoing Clinical Trials by Leading Sponsors
Figure 14: Insulinoma Average Enrollment by Phase
Figure 15: Insulinoma Average Enrollment by Trial Status
Figure 16: Insulinoma Average Enrollment by Type
Figure 17: Insulinoma- Average Enrolment by Type of Sponsors
Figure 18: Insulinoma- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Insulinoma Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Insulinoma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Insulinoma Average Enrollment by Phase
Table 15: Insulinoma Average Enrollment by Trial Status
Table 16: Insulinoma Average Enrollment by Type
Table 17: Insulinoma- Average Enrolment by Type of Sponsors
Table 18: Insulinoma- Enrolment by Leading Sponsors


More Publications